Real‐world analysis of main clinical outcomes in patients with polycythemia vera treated with ruxolitinib or best available therapy after developing resistance/intolerance to hydroxyureaAlberto Álvarez‐Larrán, Montse Gómez, Regina García et al.|Cancer|2022Cited by 32
Machine Learning Improves Risk Stratification in Myelofibrosis: An Analysis of the Spanish Registry of MyelofibrosisAdrián Mosquera-Orgueira, Manuel Pérez‐Encinas, Alberto Hernández‐Sánchez et al.|HemaSphere|2022Cited by 30
Predictors of thrombosis and bleeding in 1613 myelofibrosis patients from the Spanish Registry of MyelofibrosisJuan Carlos Hernández‐Boluda, Irene Pastor‐Galán, Eduardo Arellano‐Rodrigo et al.|British Journal of Haematology|2022Cited by 16
Machine Learning Improves Risk Stratification in Myelofibrosis: An Analysis of the Spanish Registry of MyelofibrosisAdrián Mosquera Orgueira, Juan Carlos Hernández‐Boluda, Manuel Pérez‐Encinas et al.|Blood|2022Cited by 2
Survival outcomes and treatment patterns in myelofibrosis in the <scp>JAK</scp> inhibitor eraJuan Carlos Hernández‐Boluda, the Spanish MPN Group (GEMFIN), Eduardo Arellano‐Rodrigo et al.|British Journal of Haematology|2026Cited by 0